山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (3): 70-80.doi: 10.6040/j.issn.1673-3770.0.2020.374
林小燕,李静,马志祺,李依琳,高馨怡,李勇
LIN Xiaoyan, LI Jing, MA Zhiqi, LI Yilin, GAO Xinyi, LI Yong
摘要: 目的 系统性评价益生菌对变应性鼻炎的疗效及抗变态反应作用的影响。 方法 计算机检索PubMed、Cochrane Library、Embase、中国知网、万方和维普数据库,收集以益生菌为干预措施治疗变应性鼻炎的随机对照试验(RCT),检索时限从建库截至2020年3月。由2名研究者按照纳入与排除标准独立筛选文献、提取资料和评价纳入研究的方法学质量,并采用RevMan5.3软件进行Meta分析。 结果 总共纳入27个RCT,共2 147例患者,其中试验组1 106例,对照组1 041例。Meta分析结果显示:长期口服益生菌(≥12周)可以降低过敏性鼻炎患者血清总IgE水平[SMD=-0.22,95%CI(-0.42,-0.02),P=0.03<0.05]及血嗜酸性粒细胞水平[SMD=-0.38,95%CI(-0.69,-0.08),P=0.01<0.05];且益生菌组的鼻部RQLQ[MD=-0.78,95%CI(-0.96,-0.61),P<0.000 01]、眼部RQLQ评分[MD=-0.75,95%CI(-0.90,-0.60),P<0.001]、TNSS评分[MD=-1.54,95%CI(-1.77,-1.31),P<0.001]及药物使用评分[SMD=-0.43,95%CI(-0.64,-0.22),P<0.000 01]均较安慰组较低,差异有统计学意义。但益生菌组较安慰剂组在降低血清特异性IgE水平[SMD=0.08,95%CI(-0.11,0.26),P=0.42]及调节Th1/Th2平衡[SMD=0.40,95%CI(-1.20,1.99), P=0.63]方面差异无统计学意义。 结论 口服益生菌可以有效的控制变应性鼻炎患者的过敏症状,虽然短期内口服益生菌对AR 的发生无明显预防作用,但长期服用可以降低血清总IgE水平及嗜酸性粒细胞计数水平,证明长期口服益生菌可能是治疗变应性鼻炎的一种疗效和安全性较为理想的辅助治疗手段。
中图分类号:
[1] Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis[J]. Otolaryngol Head Neck Surg, 2015, 152(1 suppl): S1-43. doi:10.1177/0194599814561600. [2] Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma(ARIA)guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation(GRADE)and real-world evidence[J]. J Allergy Clin Immunol, 2020, 145(1): 70-80.e3. doi:10.1016/j.jaci.2019.06.049. [3] Wallace DV, Dykewicz MS, Oppenheimer J, et al. Pharmacologic treatment of seasonal allergic rhinitis: synopsis of guidance from the 2017 joint task force on practice parameters[J]. Ann Intern Med, 2017, 167(12): 876. doi:10.7326/m17-2203. [4] Yan F, Polk DB. Probiotics and immune health[J]. Curr Opin Gastroenterol, 2011, 27(6): 496-501. doi:10.1097/mog.0b013e32834baa4d. [5] Colbey C, Cox AJ, Pyne DB, et al. Upper respiratory symptoms, gut health and mucosal immunity in Athletes[J]. Sports Med, 2018, 48(1): 65-77. doi:10.1007/s40279-017-0846-4. [6] Dennis-Wall JC, Culpepper T, Nieves C, et al. Probiotics(Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2)improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial[J]. Am J Clin Nutr, 2017, 105(3): 758-767. doi:10.3945/ajcn.116.140012. [7] Chen YS, Jan RL, Lin YL, et al. Randomized placebo-controlled trial of Lactobacillus on asthmatic children with allergic rhinitis[J]. Pediatr Pulmonol, 2010, 45(11): 1111-1120. doi:10.1002/ppul.21296. [8] Ciprandi G, Vizzaccaro A, Cirillo I, et al. Bacillus clausii effects in children with allergic rhinitis[J]. Allergy, 2005, 60(5): 702-703. doi:10.1111/j.1398-9995.2005.00722.x. [9] Miraglia del Giudice M, Indolfi C, Capasso M, et al. Bifidobacterium mixture(B longum BB536, B infantis M-63, B breve M-16V)treatment in children with seasonal allergic rhinitis and intermittent asthma[J]. Italian J Pediatr, 2017, 43(1): 1-6. doi:10.1186/s13052-017-0340-5. [10] Costa DJ, Marteau P, Amouyal M, et al. Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial(GA2LEN Study)[J]. Eur J Clin Nutr, 2014, 68(5): 602-607. doi:10.1038/ejcn.2014.13. [11] Giovannini M, Agostoni C, Riva E, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis[J]. Pediatr Res, 2007, 62(2): 215-220. doi:10.1203/pdr.0b013e3180a76d94. [12] Ishida Y, Nakamura F, Kanzato H, et al. Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial[J]. Biosci Biotechnol Biochem, 2005, 69(9): 1652-1660. doi:10.1271/bbb.69.1652. [13] Ishida Y, Nakamura F, Kanzato H, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study[J]. J Dairy Sci, 2005, 88(2): 527-533. doi:10.3168/jds.S0022-0302(05)72714-4. [14] Lin WY, Fu LS, Lin HK, et al. evaluation of the effect of Lactobacillus paracasei(HF.A00232)in children(6-13 years old)with perennial allergic rhinitis: a 12-week, Double-blind, randomized, Placebo-controlled study[J]. Pediatr Neonatol, 2014, 55(3): 181-188. doi:10.1016/j.pedneo.2013.10.001. [15] Lin TY, Chen CJ, Chen LK, et al. Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: a randomized double blind controlled trial[J]. Indian Pediatr, 2013, 50(2): 209-213. doi:10.1007/s13312-013-0068-2. [16] Kawase M, He F, Kubota A, et al. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study[J]. Int J Food Microbiol, 2009, 128(3): 429-434. doi:10.1016/j.ijfoodmicro.2008.09.017. [17] Meng Q, Li P, Li Y, et al. Broncho-vaxom alleviates persistent allergic rhinitis in patients by improving Th1/Th2 cytokine balance of nasal mucosa[J]. Rhinology, 2019, 57(6): 451-459. doi:10.4193/rhin19.161. [18] Moreira A, Kekkonen R, Korpela R, et al. Allergy in marathon runners and effect of Lactobacillus GG supplementation on allergic inflammatory markers[J]. Respir Med, 2007, 101(6): 1123-1131. doi:10.1016/j.rmed.2006.11.015. [19] Nishimura I, Igarashi T, Enomoto T, et al. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis[J]. Allergol Int, 2009, 58(2): 179-185. doi:10.2332/allergolint.O-08-548. [20] Ogawa T, Hashikawa S, Asai Y, et al. A new synbiotic, Lactobacillus casei subsp.caseitogether with dextran, reduces murine and human allergic reaction[J]. FEMS Immunol Med Microbiol, 2006, 46(3): 400-409. doi:10.1111/j.1574-695x.2006.00046.x. [21] Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite[J]. Pediatr Allergy Immunol, 2005, 16(5): 433-438. doi:10.1111/j.1399-3038.2005.00284.x. [22] Tamura M, Shikina T, Morihana T, et al. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial[J]. Int Arch Allergy Immunol, 2007, 143(1): 75-82. doi:10.1159/000098318. [23] Wang MF, Lin HC, Wang YY, et al. Treatment of perennial allergic rhinitis with lactic acid bacteria[J]. Pediatr Allergy Immunol, 2004, 15(2): 152-158. doi:10.1111/j.1399-3038.2004.00156.x. [24] Xiao JZ, Kondo S, Yanagisawa N, et al. Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial[J]. J Investig Allergol Clin Immunol, 2006, 16(2): 86-93. [25] Xiao JZ, Kondo S, Yanagisawa N, et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial[J]. Clin Exp Allergy, 2006, 36(11): 1425-1435. doi:10.1111/j.1365-2222.2006.02575.x. [26] Gotoh M, Sashihara T, Ikegami S, et al. Efficacy of oral administration of a heat-killed Lactobacillus gasseri OLL2809 on patients of Japanese cedar pollinosis with high Japanese-cedar pollen-specific IgE[J]. Biosci Biotechnol Biochem, 2009, 73(9): 1971-1977. doi:10.1271/bbb.90144. [27] Yonekura S, Okamoto Y, Okawa T, et al. Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis[J]. Allergy Asthma Proc, 2009, 30(4): 397-405. doi:10.2500/aap.2009.30.3256. [28] Nagata Y, Yoshida M, Kitazawa H, et al. Improvements in seasonal allergic disease with Lactobacillus plantarum no. 14[J]. Biosci Biotechnol Biochem, 2010, 74(9): 1869-1877. doi:10.1271/bbb.100270. [29] Lue KH, Sun HL, Lu KH, et al. A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12 years[J]. Int J Pediatr Otorhinolaryngol, 2012, 76(7): 994-1001. doi:10.1016/j.ijporl.2012.03.018. [30] Singh A, Hacini-Rachinel F, Gosoniu ML, et al. Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial[J]. Eur J Clin Nutr, 2013, 67(2): 161-167. doi:10.1038/ejcn.2012.197. [31] Dölle S, Berg J, Rasche C, et al. Tolerability and clinical outcome of coseasonal treatment with Escherichia coli Strain nissle 1917 in grass pollen-allergic subjects[J]. Int Arch Allergy Immunol, 2014, 163(1): 29-35. doi:10.1159/000356328. [32] 陈红江, 高明华, 邹帆, 等. 特异益生菌株对变应性鼻炎患者的免疫调节作用[J]. 第三军医大学学报, 2015, 37(2): 154-157. doi:10.16016/j.1000-5404.201408120. CHEN Hongjiang, GAO Minghua, ZOU Fan, et al. Immunomodulation effect of specific probiotics in allergic rhinitis patients[J]. Journal of Third Military Medical University, 2015, 37(2): 154-157. doi:10.16016/j.1000-5404.201408120. [33] Kim HJ, Kim HY, Lee SY, et al. Clinical efficacy and mechanism of probiotics in allergic diseases[J]. Korean J Pediatr, 2013, 56(9): 369-376. doi:10.3345/kjp.2013.56.9.369. [34] Zhou Z, Chen X, Sheng H, et al. Engineering probiotics as living diagnostics and therapeutics for improving human health[J]. Microb Cell Fact, 2020, 19(1): 56. doi:10.1186/s12934-020-01318-z. [35] 张清照, 嶋田貴志, 程雷,等. 肠球菌属益生菌提取物LFK对变应性鼻炎小鼠血清IL-12的影响[J]. 山东大学耳鼻喉眼学报, 2014, 28(3): 7-9. doi:10.6040/j.issn.1673-3770.0.2014.154. ZHANG Qingzhao, SHIMADA Takashi, CHENG Lei, et al. Effect of lysed enterococcus faecalis FK-23(LFK)on serum IL-12 in allergic rhinitis mice[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2014, 28(3): 7-9.doi:10.6040/j.issn.1673-3770.0.2014.154. [36] Vliagoftis H, Kouranos VD, Betsi GI, et al. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials[J]. Ann Allergy Asthma Immunol, 2008, 101(6): 570-579. doi:10.1016/S1081-1206(10)60219-0. |
[1] | 李世金,唐昂藏,杨必,王将栏,刘陇黔. 虚拟现实视觉训练对集合不足长期疗效的观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 35-40. |
[2] | 梁旭,史丽. 慢性鼻窦炎生物靶向药物治疗的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 30-35. |
[3] | 宜若男,陈福权. 嗜酸性粒细胞与嗅觉功能障碍[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 50-55. |
[4] | 谷钰,万鑫,肖自安. 中性粒细胞和嗜酸性粒细胞在慢性鼻窦炎中的相互影响及临床治疗思考[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 56-63. |
[5] | 倪璟滋,万文锦,程雷. 变应性鼻炎健康相关生活质量研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 110-115. |
[6] | 林一杭,李幼瑾. 肠道微生态在儿童变应性鼻炎中的研究现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 116-122. |
[7] | 刘真,宋西成. 细胞焦亡在变应性鼻炎中的作用机制及研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 123-129. |
[8] | 王娜,柴向斌. 前列腺源性ETS因子在哮喘及鼻黏膜炎性疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 136-141. |
[9] | 刘一潼,周穗子,邱前辉. NLRP3炎症小体在慢性鼻窦炎和变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 142-146. |
[10] | 梁旭,金鹏,赵莉,于克娜,訾晓雪,袁光美,臧以冉,张勤勤,张海令,史丽,张红萍. 鼻呼出一氧化氮对慢性鼻窦炎诊断的临床应用价值[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 181-188. |
[11] | 林曼青,周敏,陈腾宇,李丹,方彩珊,王睿智,朱锦祥,阮岩,徐慧贤,王培源. 中药鼻腔冲洗治疗慢性鼻窦炎术后有效性和安全性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 209-225. |
[12] | 姜雪莲, 张静月, 卫旭东. 基于Meta分析桥接网络药理学的鼻渊通窍颗粒治疗慢性鼻窦炎的疗效评价及潜在机制研究[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 226-236. |
[13] | 龚霄阳,程雷. 新冠疫情期间基于门诊患者的变应性鼻炎患者比例构成分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 245-255. |
[14] | 鹿伟理,姜涛,李宪华. 多重致敏儿童变应性鼻炎患者sIgE特征分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 260-265. |
[15] | 黄开月,李雪情,韩国鑫,张勤修. 基于“肺脾”理论指导穴位埋线治疗变应性鼻炎的Meta分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 266-274. |
|